Odyssey Therapeutics bags $168 million to expand its range of cancer drugs
Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing within ten months of disclosing a $218 ...
Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing within ten months of disclosing a $218 ...
© 2023 ustechtimes.com